AECC South Industry Co., Ltd.

Hunan Erkang Pharmaceutical Co., Ltd. (stock code: 300267) was established in October 2003 and listed on the Shenzhen Stock Exchange on September 27, 2011. The company is located in the picturesque Liuyang Economic and Technological Development Zone. Since its inception, the company has been engaged in the research, development, production, and sales of pharmaceutical products, mainly including pharmaceutical excipients, active pharmaceutical ingredients, and new antibiotics.
The company is one of the largest professional pharmaceutical excipient manufacturers in China with the most comprehensive product variety, and is one of the few enterprises in China that hold the registration approvals for the new penicillin antibiotic sulbenicillin sodium, both as an API and as a finished drug.
Erkang Pharmaceutical is a standard setter and promoter in the domestic pharmaceutical excipient industry, adhering to the business philosophy of "Professionalism for the future, quality for brilliance," achieving specialized production, serialized products, scientific application, and quality service. At the same time, the company takes "Everything for drug safety" as its mission, regarding the quality and safety of pharmaceutical excipients and other products as the life of the enterprise. Leveraging its advantages in the field of pharmaceutical excipients, the company strives to improve the quality level of pharmaceutical excipients, promote the construction of a standard system for pharmaceutical excipients, actively develop excipient products for various formulations, achieve product scale and quality standardization, and strive to become the leader in China's pharmaceutical excipient industry.
Honors received since listing:
In August 2011, awarded "Top Ten Pharmaceutical Raw Material and Excipient Brands."
In January 2012, awarded by Forbes: 2012 China's Most Promising ChiNext Listed Company (7th place).
In July 2012, awarded the 2011 Golden Bull Best Growth Company of ChiNext (2nd place).
In August 2013, awarded "Top 20 Value of China's ChiNext Listed Companies" (8th place) and "Top 10 Management Teams of China's ChiNext Listed Companies" (10th place); awarded the 2012 (6th) Pharmaceutical Industry "Top 10 National Brands" title.
In February 2014, honored with "2013 Changsha Industrial Top 30" and "2013 Enterprise with Profits and Taxes Exceeding 100 Million Yuan".